Press and News Items

support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

Press

Our News

View:
format_list_bulleted grid_view

12/16/2024

CHEPLAPHARM acquires Gemzar® from Lilly
Press releases
Read more chevron_right

11/08/2024

Sebastian Braun wins EY Entrepreneur of the Year
Press releases
Read more chevron_right

10/03/2024

Expansion in Oncology: CHEPLAPHARM reaches agreement with Lilly on acquisition of Gemzar®
Press releases
Read more chevron_right

07/17/2024

CHEPLAPHARM reorganises Management Team
Press releases
Read more chevron_right

05/15/2024

CHEPLAPHARM expands oncology portfolio with Tarceva® from Roche
Press releases
Read more chevron_right

04/26/2024

CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth
Press releases
Read more chevron_right

04/03/2024

Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS
Press releases
Read more chevron_right

01/25/2024

CHEPLAPHARM strengthens oncology portfolio with the acquisition of Myocet® from Teva
Press releases
Read more chevron_right

01/18/2024

CHEPLAPHARM acquires Roaccutane® from Roche
Press releases
Read more chevron_right

Archive

Back to top expand_less